retatrutide phase 2 nejm 2023 obesity trial results Availability & Timeline 2023年度回顧】 NEJM Notable Articles of

Independent scientists have said that BPC-157 appears promising in lab studiesbut with major caveats

Over a period of 50 days, 11 postmenopausal women received six different treatments: soy cotyledon (the first leaves to appear on the plant), soy germ, kudzu (a plant used in traditional and folk medicine), red clover, risedronate (a drug used to treat osteoporosis), and estrogen combined with progesterone

The use of recombinant human growth hormone to protect against muscle weakness in patients undergoing anterior cruciate ligament reconstruction: A pilot, randomized placebo-controlled trial

This shorter duration of action makes IGF-1 DES more suitable for research needing acute, localized effects or where rapid clearance is desired